Acticor Biotech

Basking Biosciences

The company develops reversible therapies targeting von Willebrand Factor for patients with acute thrombotic conditions, such as strokes.

Biomedical Solutions

This company develops endovascular thrombus removal devices for healthcare providers to treat patients suffering from acute ischemic stroke.

Aeromics

This pharmaceutical company develops an intravenous drug to treat brain swelling in patients suffering from severe ischemic stroke.

TargED Biopharmaceuticals

The company develops targeted biological drugs to treat thrombotic diseases such as acute ischaemic stroke and immune-mediated thrombotic thrombocytopenic purpura for healthcare providers.

Julier Medical

This company develops an expandable endovascular catheter platform and mechanical thrombectomy devices for clinicians to treat patients experiencing acute ischemic strokes.

Aptatargets

The company develops aptamer-based therapeutic drugs for patients with acute ischemic stroke and other inflammatory or cardiovascular diseases.

Navigantis

This company develops an interventional robotic platform for neurovascular procedures to assist physicians in treating conditions such as acute ischemic stroke.

Anaconda Biomed

This medical technology company develops self-expanding funnel catheters for neurovascular mechanical thrombectomy procedures, serving hospitals and clinics treating patients with acute ischemic stroke.